Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma
about
Deficient expression of aldehyde dehydrogenase 1A1 is consistent with increased sensitivity of Gorlin syndrome patients to radiation carcinogenesisContemporary management of stage I and II seminoma.Proton radiotherapy for gynecologic neoplasms.Comparing proton treatment plans of pediatric brain tumors in two pencil beam scanning nozzles with different spot sizes.Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model.Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.[Clinical stage I seminoma. Is surveillance a new therapy standard?].
P2860
Q28389106-0ADC9D90-335A-4E3D-A878-4FCA2A1F582AQ30352886-05941D30-3C0F-4718-AC57-1E13C56A21C7Q38921612-CED89EB0-DE4D-4669-8E83-644455F0F01AQ40176502-53E69810-F548-4E25-B46C-22243D43BECAQ41162730-36424188-27BC-420A-805D-0A9461931967Q44195290-03110697-C74D-48D3-8055-B8E641777D93Q44956406-F0D8178F-AD77-4D57-88EE-3B6A926BE96A
P2860
Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predicted rates of secondary m ...... n therapy for stage I seminoma
@ast
Predicted rates of secondary m ...... n therapy for stage I seminoma
@en
type
label
Predicted rates of secondary m ...... n therapy for stage I seminoma
@ast
Predicted rates of secondary m ...... n therapy for stage I seminoma
@en
prefLabel
Predicted rates of secondary m ...... n therapy for stage I seminoma
@ast
Predicted rates of secondary m ...... n therapy for stage I seminoma
@en
P2093
P2860
P1476
Predicted rates of secondary m ...... n therapy for stage I seminoma
@en
P2093
Arnaud Belard
James McDonough
John O'Connell
Justin E Bekelman
Kevin Kramer
William P O'Meara
P2860
P304
P356
10.1016/J.IJROBP.2010.11.021
P407
P577
2011-01-13T00:00:00Z